Bellucci, Gianmarco
 Distribuzione geografica
Continente #
EU - Europa 405
NA - Nord America 344
AS - Asia 185
AF - Africa 13
SA - Sud America 6
OC - Oceania 4
Totale 957
Nazione #
US - Stati Uniti d'America 338
IT - Italia 245
SG - Singapore 97
SE - Svezia 36
CN - Cina 26
RU - Federazione Russa 20
DE - Germania 19
IN - India 19
ID - Indonesia 18
GB - Regno Unito 15
BG - Bulgaria 13
TR - Turchia 13
FI - Finlandia 11
TG - Togo 11
NL - Olanda 10
IE - Irlanda 7
LT - Lituania 6
TW - Taiwan 6
BE - Belgio 5
BR - Brasile 5
CH - Svizzera 5
AU - Australia 4
CA - Canada 4
FR - Francia 4
UA - Ucraina 4
GR - Grecia 2
IL - Israele 2
IR - Iran 2
MX - Messico 2
RO - Romania 2
AT - Austria 1
CL - Cile 1
KR - Corea 1
LB - Libano 1
SC - Seychelles 1
UG - Uganda 1
Totale 957
Città #
Rome 92
Singapore 80
Chandler 40
Santa Clara 34
Ashburn 25
Fairfield 19
Jakarta 18
Boardman 15
Milan 15
Cambridge 14
Sofia 13
Houston 12
Princeton 12
Lomé 11
Helsinki 10
New York 10
Pune 9
Wilmington 8
Ankara 7
Boston 7
London 7
San Paolo di Civitate 7
Woodbridge 7
Bologna 6
Naples 6
Taipei 6
Andover 5
Fasano 5
Lawrence 5
Parma 5
San Diego 5
Verona 5
Arielli 4
Brussels 4
Dublin 4
Frankfurt am Main 4
Millbury 4
Nuremberg 4
Florence 3
Hebei 3
Lyon 3
Menlo Park 3
Moscow 3
Philadelphia 3
Seattle 3
Toronto 3
Yubileyny 3
Amsterdam 2
Ann Arbor 2
Beijing 2
Brugherio 2
Brusciano 2
Buccinasco 2
Camporgiano 2
Chalcis 2
Fermo 2
Gatteo 2
Genzano di Roma 2
Guangzhou 2
Melbourne 2
Oxford 2
Rieti 2
Sedico 2
Stockholm 2
Sydney 2
Tehran 2
Villaricca 2
Winterthur 2
Avella 1
Bad Bellingen 1
Baltimore 1
Bari 1
Bengaluru 1
Bonndorf 1
Bracciano 1
Bremen 1
Bühl 1
Campo Grande 1
Capena 1
Cariacica 1
Carouge 1
Chiampo 1
Civitavecchia 1
DeKalb 1
Deinze 1
Dongyang 1
Formello 1
Gelsenkirchen 1
Hamburg 1
Lappeenranta 1
Laurel 1
Mahé 1
Manassas 1
Mexico City 1
Monmouth Junction 1
Munich 1
Ottawa 1
Padova 1
Perdões 1
Pescara 1
Totale 645
Nome #
A case of double standard. Sex differences in multiple sclerosis risk factors 106
Reworking GWAS data to understand the role of nongenetic factors in MS etiopathogenesis 78
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington’s Disease: A Pilot Study 75
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets 72
Mait cells and microbiota in multiple sclerosis and other autoimmune diseases 65
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? 56
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 52
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 52
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS 51
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome 48
Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint 46
ADEM after ChAdOx1 nCoV-19 vaccine. A case report 46
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review 45
Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease 41
Frailty and relapse activity in multiple sclerosis: A longitudinal observation 40
Disentangling multiple sclerosis phenotypes through mendelian disorders: A network approach 39
Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report 30
Blurred lines: bilateral optic perineuritis mimicking idiopathic intracranial hypertension 29
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease: A Pilot Study 20
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review 20
Clinical and immunological impact of ocrelizumab extended interval dosing in multiple sclerosis: a single-center, real-world experience 12
Gut microbiota composition is causally linked to multiple sclerosis: a mendelian randomization analysis 12
Leukocyte telomere length variability as a potential biomarker in patients with polyQ diseases 12
Long-term follow-up before and during riluzole treatment in six patients from two families with spinocerebellar ataxia type 7 8
COVID-19 severity in multiple sclerosis 5
null 3
Totale 1.063
Categoria #
all - tutte 5.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 0 0 7 4 3 3 0
2020/202122 3 0 3 0 0 0 4 5 1 3 1 2
2021/2022192 13 15 8 4 11 14 7 6 11 1 26 76
2022/2023210 30 37 15 15 21 14 6 23 25 0 10 14
2023/2024255 16 14 5 11 23 65 16 13 9 28 23 32
2024/2025367 22 62 40 76 51 72 44 0 0 0 0 0
Totale 1.063